IAG and Collaborators will Present at American Society of Clinical Oncology (ASCO), June 4-8, 2021
IAG, Image Analysis Group, a strategic partner to life-sciences companies developing novel treatments, today announced that two abstracts will be presented at this year’s American Society Clinical Oncology Virtual Conference, ASCO21.
The abstracts are based upon the data from IAG and biotech partner Genenta Science’s latest clinical research studies, and discuss how advanced imaging and integrated use of AI can aid cancer drug development by assessing response earlier and more accurately.
The accepted abstracts are:
Title: “Integrated use of AI tumor volumetrics and advanced MRI to assess early response to Temferon™ in a Phase-2 GBM trial: a novel paradigm.”
Authors: Sotirios Bisdas, Diana Dupont-Roettger, Valeria Cuccarini, Bernhard Gentner, Marica Eoli , Luigi Naldini, Fabio Ciceri, Gaetano Finocchiaro, Carlo Russo , Maria Grazia Bruzzone
Access Online: https://meetinglibrary.asco.org/record/199331/abstract
Title: “A phase I-IIa study of genetically modified Tie-2 expressing monocytes in patients with glioblastoma multiforme (TEM-GBM Study).”
Authors: Gaetano Finocchiaro, Bernhard Gentner, Francesca Farina, Alessia Capotondo, Marica Eoli, Elena Anghileri, Matteo Giovanni Carabba, Valeria Cuccarini, Francesco Di Meco, Federico Legnani, Bianca Pollo, Maria Grazia Bruzzone, Marco Saini, Paolo Ferroli, Roberto Pallini, Alessandro Olivi, Stefania Mazzoleni, Carlo Russo, Luigi Naldini, Fabio Ciceri;
Access Online: https://meetinglibrary.asco.org/record/196162/abstract
Send your questions to firstname.lastname@example.org
Prof. Sotirios Bisdas is IAG’s Senior Director of Neuro-Oncology Research. He is a consultant neuroradiologist and MRI Lead in the Department of Neuroradiology at the National Hospital for Neurology in London, Senior Lecturer in Neuroradiology at the Institute of Neurology University College London, and Professor of Radiology at Eberhard Karls University in Tübingen, Germany. He has authored over 130 peer-reviewed publications and serves as member of the editorial board of several leading journals in Radiology and Neuroradiology. He is also reviewer for leading journals in Neuroimaging, member of the Executive Committee of the European Society of Head and Neck Radiology, and member of the Head and Neck committee of the European Society of Neuroradiology.
Dr. Diana Dupont-Roettger is IAG’s Chief Scientific Alliance Officer. She is a Medical Computer Scientist by background with strong experience in novel imaging technologies and imaging markers and their role in clinical trials. She advises biopharmaceutical companies on the strategic use of advanced imaging to evaluate mechanism of action, enable precision medicine and accelerate drug development in immuno-oncology and neuro-oncology indications. Diana is actively working with biotech, pharma and investment funds helping to bridge the gap between academic research, business objectives and finances.
is a strategic partner to bio-pharmaceutical companies developing new treatments to improve patients’ lives. IAG broadly leverages its core imaging expertise, proprietary technology platform DYNAMIKA and capabilities to support an objective early go no/ go decision and drive excellence for tomorrow’s innovative therapeutic agents with speed. We fuse decades of therapeutic insights, risk-sharing business model and agile culture to accelerate novel drug development.
If you are interested in meeting our expert team at ASCO’21 Virtual Conference please email <imaging.experts@@ia-grp.com>